A 54-year-old woman was referred for evaluation of an orbital tumour after 5 months of non-specific ophthal mic symptoms. Tissue obtained by an open orbital biopsy was highly suspicious for asymptomatic meta static breast carcinoma, which was discovered a few weeks later. Unlike the primary tumour, which was an invasive lobular breast carcinoma, the metastatic tissue was repeatedly negative for oestrogen and progester one receptor markers. A possible reason is a change in cellular cytoplasmic and nuclear protein composition during the metastatic process. Since the primary tumour was positive for the hormone receptors, the patient was treated by chemotherapy and tamoxifen. The follow-up supports a favourable effect of adjuvant endocrinolo gical therapy even in cases with receptor-negative metastatic tissue. This report is in partial contradiction to some previously published cases and emphasises the role of receptor status in the primary tumour.
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Breast carcinoma is one of the most common malignant diseases in women. The common sites of remote metastases are bone, lung and liver. 1 Metas tases to the eye (choroid) and the ocular adnexa account for 2-4% of all metastatic sites, 1 but have also been reported to have a prevalence of 27% when undiagnosed cases are included. women this figure is as high as 62%. 6 Orbital metastases from breast cancer have an average delay of some 3-5 years after detection of a primary tumour. 3 • 7 -9 Therefore, there are only sporadic reports in the literature where the diagnosis of metastatic mammary carcinoma ('occult primary') was made on orbital tissue. 3 , 7 , 8 , lO , 11 In view of the increasingly sophisticated methods available for the detection of the primay cancer one would expect a decrease in the number of such reports.
Within the last decade, the development of techniques for the detection of oestrogen receptors (ER) and progesterone receptors (PR) in tumorous tissue suggests that testing orbital biopsy tissue for the presence of these receptors is of value. ll In the following case of an occult breast carcinoma we report our experience in hormone receptor testing on metastatic tissue. We also discuss its value and possible pitfalls.
CASE REPORT
A 54-year-old white woman was referred to our department with a 3-week history of a painless firm mass in the inner part of the left upper lid. She reported recurrent 'conjunctival and corneal inflam mations' for the preceding 5 months. The referring ophthalmologist obtained a CT scan that showed a 'parabulbar tumour'; no further details were given. The patient's medical and ocular history was negative except for mild hyperopia, presbyopia and an appendectomy.
On examination, the corrected visual acuity was 20/20 (1, 0) in the right eye and 20/25 (0,9) in the left eye. There was a moderate left upper lid ptosis. A firm mass 1.5 x 0.7 mm was palpable at the medial aspect of the upper lid and appeared to adhere to the upper orbital margin. There was no proptosis, but left elevation and abduction were partially impaired. Slit lamp and fundus examination as well
Eye (1997) as computer visual fields did not show any significant abnormalities.
A-and B-scan ultrasonography demonstrated a supero-medial and partially retrobulbar lesion with a low internal reflectivity and a probable erosion of the orbital roof. A contrast-enhanced CT scan in our hospital revealed diffuse infiltration of the orbital fat posteriorly with involvement of the medial rectus muscle and some soft tissue changes in the medial and lateral canthal regions (Fig. 1) . The list of differential diagnoses included lymphoma, optic nerve sheath meningioma, glioma and chronic inflammatory pseudotumour. The findings of a general physical examination, liver ultrasound and chest radiograph in the Department of Oncology were reported as negative. Thus, a decision was made to proceed with an orbital incisional biopsy through a transpalpebral approach. At surgery the lesion infiltrated the orbicularis muscle and was partially adherent to the dermis. The clinical appearance immediately after biopsy IS shown in Fig. 2 .
The pathological specimen measured 6 x 5 x 5 mm, was firm and of a reddish colour. Microscopy disclosed multiple striated muscle fibres and connective tissue with some orbital fat. The entire structure was diffusely infiltrated by bundles of atypical middle-sized cells with partially irregular nuclei (Fig. 3a) . Some of the cells contained cytoplasmic vacuoles that were positive on periodic acid-Schiff (PAS) stain (Fig. 3a) . Because of a high suspicion of metastatic breast carcinoma, immuno histochemistry was carried out using a cytokeratin marker (clone MNF 116, code no. M0821, DAKO, Denmark), as well as monoclonal antibodies against nuclear oestrogen (DAKO-ER, 1D5, DAKO, Den mark) and progesterone receptors (DAKO Anti Human PR, code no. A 0098, DAKO, Denmark) . While there was positivity for cytokeratin (Fig. 3b ) the ER and PR reaction was negative. As expected tumour cells did not react with vimentin, leucocyte antigen (LCA), B-Iymphocytes (L26) or T-Iympho cytes (UCHL-1, CD 20-RO).
When the patient was informed, she said she had a small 'superficial ulcer close to the right nipple' of a few days' duration. She was referred to the Depart ment of Gynaecology and Obstetrics and a bilateral breast carcinoma with lymph node involvement was discovered. A bilateral mastectomy with dissection of the axillary lymph nodes was performed 6 months after the onset of ocular symptoms and 9 weeks after the initial presentation to an ophthalmologist.
On histological examination the breast tumour was diagnosed as an invasive lobular carcinoma. The cytology of the cells (Fig. 4a) was very similar to that seen in the orbit. Surprisingly, the primary tumour was highly positive for ER (Remmele score = 12) (Fig. 4b) and positive for PR (score = 4). The final TNM staging was pT4 Nbiii Gl. Since the mastect omy the patient has received six chemotherapy cycles (VNC = Vindesine, Novantrone, Cyclophosphamide) and is on tamoxifen 30 mg/day. The swelling of the left upper lid disappeared and the motility distur bances resolved. Over 2 years after the first presentation the patient is well with no other metastases detected. Our patient is in many respects interesting for review purposes. At the time of initial presentation she was 54 years old -the mean age given by Bullock and Yanes 8 in their series of 30 patients. Similarly, typical findings in breast metastasis are ptosis, a palpable mass and ocular motility restriction 7 . 9, 1 3 , 1 5 -the last sign noted by Horner as early as 1864 ? Enophthalmos or proptosis may also be seen depending on the metastatic growth pattern (infiltra tion versus mass) 1 2 and histological type. lO The involvement of the superior orbit is very common, s explaining the observed ptosis.
The most striking finding in our case was the discrepancy in the hormonal receptor status between the orbital open biopsy tissue and the primary tumour. While the metastatic tissue was repeatedly negative for both oestrogen and progesterone receptors, the scores for the main tumour were 12 (maximum) and 4, respectively. We are aware of four cases in the literature where the metastatic tissue was submitted for receptor analysis: Bullock and Yanes 8 reported two of three positive, and Reifler and Davison ll one positive. The last case is almost identical to our patient for two reasons: (1) receptors were tested on both metastatic and primary tumour specimens and (2) histologically, the primary tumour was an infiltrating lobular carcinoma. In that particular type of breast carcinoma oestrogen recep tors can be detected in up to 90% of cases. 1 The clinical significance is enormous, because with the use of the oestrogen receptor competitor tamoxifen, an average remission of 2-3 years can be achieved in the treatment of metastatic disease. 1 5 In the above mentioned reports biochemical assay 8 and a histo chemical fluorescein-labelled assay ll were used P Meanwhile, a further development of immunohisto chemistry techniques with monoclonal antibodies against the steroid hormone receptors, as in our case, simplified the routine testing.
What are the possible reasons for the discrepancy in receptor testing between the primary and the metastatic tumour tissue? A change in the ER status over time in the primary tumour also has been reported ? O Our patient has been receiving tamoxifen from the beginning of the chemotherapy. Although the follow up period is 2 years only, the patient is in remission with resolution of ophthalmic symptoms. Whether this beneficial effect is to be ascribed to chemother apy alone or its combination with tamoxifen is a matter of conjecture. Since a highly positive ER assay on the primary tumour was clearly shown to predict the response to the subsequent therapy for metastatic disease, 2o adjuvant hormone therapy should be recommended even in patients negative for hormone receptors on metastatic tissue.
